STATEMENT OF NEED / TARGET AUDIENCE

Prostate cancer is one of the most rapidly evolving fields in urologic oncology. Published results from clinical trials lead to the emergence of new surgical and radiation therapy techniques and therapeutic agents, along with changes in the indications for existing treatments. In order to offer optimal patient care — including the option of clinical trial participation — the practicing urologist and radiation oncologist must be well informed of these advances. To bridge the gap between research and practice, Prostate Cancer Update utilizes the perspectives of leading urologic oncology and radiation oncology investigators. By providing access to the latest research developments and expert opinions, this CME program assists urologists and radiation oncologists in the formulation of up-to-date clinical management strategies.

GLOBAL LEARNING OBJECTIVES

  • Critically evaluate the clinical implications of emerging clinical trial data in prostate cancer treatment and incorporate these data into management strategies in the local and advanced disease settings.
  • Counsel appropriately selected patients about the availability of ongoing clinical trials.
  • Inform prostate cancer patients about the specific risks and benefits of local and systemic therapies.
  • Provide individualized counseling to patients regarding the choice and timing of endocrine therapy.
  • Counsel appropriately selected patients in the high-risk or advanced disease settings about the risks and benefits of chemotherapy, including emerging data on taxane-based regimens.

PURPOSE OF THIS ISSUE OF PROSTATE CANCER UPDATE

The purpose of this special edition of Prostate Cancer Update is to support these objectives by offering the perspectives of Drs D’Amico, Klotz, Merrick, Petrylak, Roach and Swanson and information presented at a recent satellite symposium held in conjunction with the 2005 ASTRO annual meeting on the integration of the most recent emerging clinical research data in prostate cancer management.

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 2.75 category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.

HOW TO USE THIS CME ACTIVITY

This is an audio CME activity. To receive credit, the participant should listen to the CDs and complete the post-test and evaluation form located in this booklet or on our website, www.ProstateCancerUpdate.com.